FDMT Competitors & Alternatives
Compare 4D Molecular Therapeutics Inc with similar stocks in the same industry
Biotechnology
FDMT
Main Stock$11.65
-4.74%
Tradestie Score
52
Market Cap
$407.71M
Revenue Growth
45.1%
Analyst Upside
+141.1%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 1/10
Drug Discovery Biotech
Gene Therapy
Top Competitors
11 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BMRN
BioMarin Pharmaceuticals Inc
|
$58.32
+1.90%
|
$10.53B | - | 54 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$40.61
-3.86%
|
$6.02B | - | 49 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$21.29
-6.75%
|
$2.44B | - | 41 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$15.14
-5.76%
|
$2.02B | 802.5 | 41 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$26.54
-0.52%
|
$1.29B | - | 54 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$9.72
-5.45%
|
$354.45M | - | 47 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$3.59
-8.55%
|
$332.96M | - | 46 | Compare |
|
EDIT
Editas Medicine, Inc. Common Stock
|
$1.91
-12.21%
|
$319.22M | - | 51 | Compare |
|
NKTX
Nkarta, Inc. Common Stock
|
$1.21
+1.26%
|
$151.28M | - | 49 | Compare |
|
ALXO
ALX Oncology Holdings Inc. Common Stock
|
$0.95
-9.07%
|
$96.93M | - | 60 | Compare |
More FDMT Analysis
Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2836)
11 stocks in this industry